Authorship rules for medical journals flouted by pharma industry

(Medical Xpress) -- Rather than ensure the proper attribution of authorship, rules set up by leading medical journals to define and credit authorship of published articles are exploited by the pharmaceutical industry in its attempt to conceal and misrepresent industry contributions to the literature.

This is a perspective contained in an article by Alastair Matheson, a medical writer based in the UK and Canada, who argues in this week's that the current International Committee of Medical Journal Editors (ICMJE) authorship guidelines allow for industry to exaggerate the contribution of named academic authors and downplay that of commercial writers who are excluded from authorship but listed as contributors in the small print.

Matheson contends that the ICMJE guidelines should be fundamentally revised and the concept of origination given comparable importance to authorship and contributorship. Pharmaceutical companies and writers who work on industry publications should be listed as byline authors, he says.

In another perspective article, Linda Logdberg of Fernbank Science Center, USA, who worked in the medical communication industry for 11 years, offers her personal view of her work and why she did it, writing that " about have been directed primarily at ''guest'' authors and the pharmaceutical companies that pay them. One voice that is largely missing is that of the ghostwriters themselves who, after all, create the documents that are in the ethical and legal crosshairs. Without them, one could argue, there can be no fraud, because it is they who create the fraudulent product."

add to favorites email to friend print save as pdf

Related Stories

Warning: Ghostwriting may be hazardous to your health

Feb 02, 2010

(PhysOrg.com) -- Of the top 50 medical schools in the United States, as defined by the 2009 U.S. News & World Report’s research ranking, only 13 - or 26 percent - have publicly available policies in place that strictly ...

New strategies to tackle medical ghostwriting are debated

Feb 03, 2009

Better strategies to tackle ghostwriting in the medical literature are the subject of a debate by leading authors in next week's issue of the open-access journal PLoS Medicine. Ghostwriting is scientific misconduct, argues ...

Lost in the middle: author order matters, new paper says

Nov 05, 2007

Rare is the scientific paper today written by a single author. With research being conducted by teams of scientists, most studies now boast a half-dozen or so authors. According to a new study led by a scientist at the Oklahoma ...

Recommended for you

Why aren't there any human doctors in Star Wars?

10 hours ago

Though set "a long time ago in a galaxy far, far away," it isn't hard to see in the Star Wars films a vision of our own not so distant future. But Anthony Jones, a physician with a long background in health ...

Cambodia bans 'virgin surgery' adverts

Jan 29, 2015

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

Jan 28, 2015

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.